Skip to main content

Table 2 Results of the cost-utility analysis

From: Economic evaluation of dialysis and comprehensive conservative care for chronic kidney disease using the ICECAP-O and EQ-5D-5L; a comparison of evaluation instruments

Outcome

HD group

CCC group

Difference

Total cost (USD), mean ± SD

$11,085 ± $2,188

$2,540.48 ± $306.26

$8,544.52

QALYs based on EQ-5D-5L

2.19 ± 0.94

2.25 ± 0.96

−0.06

QALYs based on ICECAP-O

2.93 ± 1.25

2.94 ± 1.21

0.02

ICER (EQ-5D-5L)

−$141,742.67

CCC is dominant

ICER (ICECAP-O)

−$4,272.26

CCC is dominant

Net Monetary Benefit (NMB) based on EQ-5D-5L

−$311,919.01

$28,276.17

−$283,642.84

Net Monetary Benefit (NMB) based on ICECAP-O

$44,530.84

$44,110.67

$420.17